• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白细胞介素 6/s 白细胞介素 6 受体转导信号,但不是肿瘤坏死因子-α诱导的人脐静脉内皮细胞和滑膜细胞共培养系统中的血管生成。

IL-6/sIL-6R trans-signalling, but not TNF-alpha induced angiogenesis in a HUVEC and synovial cell co-culture system.

机构信息

Product Research Department, Chugai Pharmaceutical Co, Ltd, Gotemba, Shizuoka 412-8513, Japan.

出版信息

Rheumatol Int. 2009 Oct;29(12):1449-54. doi: 10.1007/s00296-009-0885-8. Epub 2009 Mar 7.

DOI:10.1007/s00296-009-0885-8
PMID:19277666
Abstract

Angiogenesis in synovia is a characteristic of RA patients. We examined whether IL-6 or TNF-alpha induce tubule formation in a co-culture system of fibroblast-like synovial cells from RA patients (RA-FLS) and human umbilical vein endothelial cells (HUVEC). The effects of IL-6 and TNF-alpha on the expression of angiogenic factors in RA-FLS and HUVEC, and the proliferation of HUVEC were also studied. IL-6 + sIL-6R induced tubule formation, whereas IL-6 alone did not. IL-6/sIL-6R-induced tubule formation was completely suppressed by the addition of either anti-IL-6R or anti-VEGF antibody. TNF-alpha did not induce tubule formation. On the contrary, it decreased CD31-positive area compared with the control. IL-6 + sIL-6R augmented VEGF production in RA-FLS, whereas IL-6 alone did not. Anti-IL-6R antibody suppressed IL-6/sIL-6R-induced VEGF production, but not spontaneous VEGF production. In contrast, TNF-alpha did not induce VEGF production from RA-FLS and HUVEC. IL-6 + sIL-6R stimulation of RA-FLS strongly induced mRNA expression of VEGF, but not of other angiogenic factors, such as EGF, bFGF, TGF-beta, IL-1, TNF-alpha and IL-8. Neither IL-6 nor IL-6/sIL-6R promoted HUVEC proliferation, whereas TNF-alpha significantly inhibited VEGF-induced HUVEC proliferation. In conclusion, IL-6/sIL-6R complex showed angiogenic activity via the production of VEGF from RA-FLS, but TNF-alpha was anti-angiogenic in our experimental system.

摘要

滑膜中的血管生成是 RA 患者的特征。我们检查了 IL-6 或 TNF-α 是否在 RA 患者的成纤维样滑膜细胞(RA-FLS)和人脐静脉内皮细胞(HUVEC)的共培养系统中诱导管形成。还研究了 IL-6 和 TNF-α对 RA-FLS 和 HUVEC 中血管生成因子表达的影响,以及 HUVEC 的增殖。IL-6+sIL-6R 诱导管形成,而单独的 IL-6 则没有。添加抗 IL-6R 或抗 VEGF 抗体完全抑制了 IL-6/sIL-6R 诱导的管形成。TNF-α 不会诱导管形成。相反,与对照相比,它减少了 CD31 阳性区域。IL-6+sIL-6R 增强了 RA-FLS 中 VEGF 的产生,而单独的 IL-6 则没有。抗 IL-6R 抗体抑制了 IL-6/sIL-6R 诱导的 VEGF 产生,但不抑制自发的 VEGF 产生。相反,TNF-α 不会诱导 RA-FLS 和 HUVEC 中 VEGF 的产生。IL-6+sIL-6R 刺激 RA-FLS 强烈诱导 VEGF 的 mRNA 表达,但不诱导其他血管生成因子,如 EGF、bFGF、TGF-β、IL-1、TNF-α 和 IL-8。IL-6 或 IL-6/sIL-6R 均未促进 HUVEC 增殖,而 TNF-α 显著抑制了 VEGF 诱导的 HUVEC 增殖。总之,IL-6/sIL-6R 复合物通过 RA-FLS 产生 VEGF 显示出血管生成活性,而 TNF-α 在我们的实验系统中具有抗血管生成作用。

相似文献

1
IL-6/sIL-6R trans-signalling, but not TNF-alpha induced angiogenesis in a HUVEC and synovial cell co-culture system.白细胞介素 6/s 白细胞介素 6 受体转导信号,但不是肿瘤坏死因子-α诱导的人脐静脉内皮细胞和滑膜细胞共培养系统中的血管生成。
Rheumatol Int. 2009 Oct;29(12):1449-54. doi: 10.1007/s00296-009-0885-8. Epub 2009 Mar 7.
2
IL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF-alpha and IL-17.白细胞介素-6转信号直接诱导成纤维样滑膜细胞上的核因子κB受体活化因子配体(RANKL),并参与肿瘤坏死因子-α和白细胞介素-17诱导RANKL的过程。
Rheumatology (Oxford). 2008 Nov;47(11):1635-40. doi: 10.1093/rheumatology/ken363. Epub 2008 Sep 11.
3
JAK inhibitors inhibit angiogenesis by reducing VEGF production from rheumatoid arthritis-derived fibroblast-like synoviocytes.JAK 抑制剂通过减少类风湿关节炎衍生的成纤维样滑膜细胞产生的 VEGF 来抑制血管生成。
Clin Rheumatol. 2024 Nov;43(11):3525-3536. doi: 10.1007/s10067-024-07142-9. Epub 2024 Sep 20.
4
Interleukin-6 upregulates expression of ADAMTS-4 in fibroblast-like synoviocytes from patients with rheumatoid arthritis.白细胞介素 6 上调类风湿关节炎患者成纤维样滑膜细胞中 ADAMTS-4 的表达。
Int J Rheum Dis. 2012 Feb;15(1):36-44. doi: 10.1111/j.1756-185X.2011.01656.x. Epub 2011 Sep 14.
5
Interleukin-6 (IL-6) induces the proliferation of synovial fibroblastic cells in the presence of soluble IL-6 receptor.白细胞介素-6(IL-6)在可溶性IL-6受体存在的情况下可诱导滑膜成纤维细胞增殖。
Br J Rheumatol. 1995 Apr;34(4):321-5. doi: 10.1093/rheumatology/34.4.321.
6
Rheumatoid arthritis synovial fibroblasts produce a soluble form of the interleukin-7 receptor in response to pro-inflammatory cytokines.类风湿关节炎滑膜成纤维细胞在促炎细胞因子的刺激下产生白细胞介素-7 受体的可溶性形式。
J Cell Mol Med. 2011 Nov;15(11):2335-42. doi: 10.1111/j.1582-4934.2010.01228.x.
7
IL-6 inhibits the proliferation of fibroblastic synovial cells from rheumatoid arthritis patients in the presence of soluble IL-6 receptor.在可溶性白细胞介素-6受体存在的情况下,白细胞介素-6抑制类风湿性关节炎患者的成纤维样滑膜细胞增殖。
Int Immunol. 2000 Feb;12(2):187-93. doi: 10.1093/intimm/12.2.187.
8
Anti-interleukin-6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritis.抗白细胞介素-6受体抗体疗法可降低类风湿关节炎中血管内皮生长因子的产生。
Arthritis Rheum. 2003 Jun;48(6):1521-9. doi: 10.1002/art.11143.
9
IL-35 Inhibits Angiogenesis through VEGF/Ang2/Tie2 Pathway in Rheumatoid Arthritis.白细胞介素-35通过VEGF/Ang2/Tie2途径抑制类风湿关节炎中的血管生成。
Cell Physiol Biochem. 2016;40(5):1105-1116. doi: 10.1159/000453165. Epub 2016 Dec 14.
10
Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation.类风湿关节炎患者滑液中的白细胞介素-6和可溶性白细胞介素-6受体是破骨细胞样细胞形成的原因。
J Bone Miner Res. 1996 Jan;11(1):88-95. doi: 10.1002/jbmr.5650110113.

引用本文的文献

1
Vasculitic Neuropathy With Iron Deficiency-Related Chronic Inflammation Followed by Elevated Serum Vascular Endothelial Growth Factor: A POEMS (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes) Syndrome Mimic.伴有缺铁相关慢性炎症的血管炎性神经病变,随后血清血管内皮生长因子升高:一种POEMS(多发性神经病、器官肿大、内分泌病、单克隆丙种球蛋白病和皮肤改变)综合征模仿症。
Cureus. 2025 Jun 5;17(6):e85384. doi: 10.7759/cureus.85384. eCollection 2025 Jun.
2
Biomaterials for Modulating the Immune Microenvironment in Rheumatoid Arthritis.用于调节类风湿关节炎免疫微环境的生物材料
BME Front. 2025 Mar 10;6:0102. doi: 10.34133/bmef.0102. eCollection 2025.
3

本文引用的文献

1
Developing and applying a gene functional association network for anti-angiogenic kinase inhibitor activity assessment in an angiogenesis co-culture model.在血管生成共培养模型中开发并应用基因功能关联网络以评估抗血管生成激酶抑制剂的活性。
BMC Genomics. 2008 Jun 2;9:264. doi: 10.1186/1471-2164-9-264.
2
Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial.托珠单抗抑制白细胞介素-6受体对类风湿关节炎患者的影响(OPTION研究):一项双盲、安慰剂对照的随机试验。
Lancet. 2008 Mar 22;371(9617):987-97. doi: 10.1016/S0140-6736(08)60453-5.
3
Case report: Tocilizumab for hypersensitivity reaction after oxaliplatin in a patient with NK/T-cell lymphoma.
病例报告:托珠单抗治疗NK/T细胞淋巴瘤患者奥沙利铂后发生的过敏反应
Front Pharmacol. 2025 Jan 15;15:1471038. doi: 10.3389/fphar.2024.1471038. eCollection 2024.
4
JAK inhibitors inhibit angiogenesis by reducing VEGF production from rheumatoid arthritis-derived fibroblast-like synoviocytes.JAK 抑制剂通过减少类风湿关节炎衍生的成纤维样滑膜细胞产生的 VEGF 来抑制血管生成。
Clin Rheumatol. 2024 Nov;43(11):3525-3536. doi: 10.1007/s10067-024-07142-9. Epub 2024 Sep 20.
5
Effects of Astragaloside IV on Hearing, Inflammatory Factors, and Intestinal Flora in Mice Exposed to Noise.黄芪甲苷IV对噪声暴露小鼠听力、炎症因子及肠道菌群的影响
Metabolites. 2024 Feb 11;14(2):122. doi: 10.3390/metabo14020122.
6
C-C Motif Chemokine Ligand 2 Enhances Macrophage Chemotaxis, Osteogenesis, and Angiogenesis during the Inflammatory Phase of Bone Regeneration.C-C 基序趋化因子配体 2 增强骨再生炎症期的巨噬细胞趋化、成骨和血管生成。
Biomolecules. 2023 Nov 18;13(11):1665. doi: 10.3390/biom13111665.
7
Mimicking lipolytic, adipogenic, and secretory capacities of human subcutaneous adipose tissue by spheroids from distinct subpopulations of adipose stromal/stem cells.通过脂肪基质/干细胞不同亚群的球体模拟人皮下脂肪组织的脂解、脂肪生成和分泌能力。
Front Cell Dev Biol. 2023 Sep 29;11:1219218. doi: 10.3389/fcell.2023.1219218. eCollection 2023.
8
Multiplex Analysis of Cytokines and Chemokines in Persons Aging With or Without HIV.多指标分析伴或不伴 HIV 老年人的细胞因子和趋化因子。
AIDS Res Hum Retroviruses. 2023 Jul;39(7):367-380. doi: 10.1089/AID.2022.0183. Epub 2023 Jun 7.
9
Hepatocyte growth factor ameliorates dextran sodium sulfate‑induced colitis in a mouse model by altering the phenotype of intestinal macrophages.肝细胞生长因子通过改变肠道巨噬细胞表型改善葡聚糖硫酸钠诱导的小鼠结肠炎。
Mol Med Rep. 2023 Mar;27(3). doi: 10.3892/mmr.2023.12957. Epub 2023 Feb 17.
10
Protein interaction, cytotoxic, transcriptomic and proteomic responses to structurally distinct EPAC1 activators in HUVECs.蛋白相互作用、细胞毒性、转录组学和蛋白质组学对 HUVECs 中结构不同的 EPAC1 激活剂的反应。
Sci Rep. 2022 Oct 5;12(1):16505. doi: 10.1038/s41598-022-20607-8.
All-trans retinoic acid induces in vitro angiogenesis via retinoic acid receptor: possible involvement of paracrine effects of endogenous vascular endothelial growth factor signaling.
全反式维甲酸通过维甲酸受体诱导体外血管生成:内源性血管内皮生长因子信号旁分泌效应可能参与其中。
Endocrinology. 2007 Mar;148(3):1412-23. doi: 10.1210/en.2006-0900. Epub 2006 Dec 14.
4
Angiogenesis as a therapeutic target in arthritis: lessons from oncology.血管生成作为关节炎的治疗靶点:肿瘤学的经验教训。
Curr Pharm Des. 2006;12(21):2631-44. doi: 10.2174/138161206777698747.
5
Angiogenesis in rheumatoid arthritis.类风湿关节炎中的血管生成
Histol Histopathol. 2006 May;21(5):557-66. doi: 10.14670/HH-21.557.
6
Functional characterization of SLCO1B1 (OATP-C) variants, SLCO1B1*5, SLCO1B1*15 and SLCO1B1*15+C1007G, by using transient expression systems of HeLa and HEK293 cells.通过使用HeLa和HEK293细胞的瞬时表达系统对SLCO1B1(OATP-C)变体SLCO1B1*5、SLCO1B1*15和SLCO1B1*15 + C1007G进行功能表征。
Pharmacogenet Genomics. 2005 Jul;15(7):513-22. doi: 10.1097/01.fpc.0000170913.73780.5f.
7
Anti-interleukin-6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritis.抗白细胞介素-6受体抗体疗法可降低类风湿关节炎中血管内皮生长因子的产生。
Arthritis Rheum. 2003 Jun;48(6):1521-9. doi: 10.1002/art.11143.
8
Telomerase rescues the expression levels of keratinocyte growth factor and insulin-like growth factor-II in senescent human fibroblasts.端粒酶可挽救衰老的人成纤维细胞中角质形成细胞生长因子和胰岛素样生长因子-II的表达水平。
Exp Cell Res. 2002 Oct 1;279(2):321-9. doi: 10.1006/excr.2002.5607.
9
Anti-TNF alpha therapy in rheumatoid arthritis--current and future directions.类风湿关节炎中的抗肿瘤坏死因子α治疗——现状与未来方向
Curr Dir Autoimmun. 2000;2:83-102. doi: 10.1159/000060499.
10
Elevated levels of vascular endothelial growth factor in the sera of patients with rheumatoid arthritis correlation with disease activity.类风湿关节炎患者血清中血管内皮生长因子水平升高与疾病活动度相关。
Life Sci. 2001 Sep 7;69(16):1861-9. doi: 10.1016/s0024-3205(01)01264-4.